Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

FDA and Justice Department Address Drug Quality Concerns

February 2, 2012

Pharmaceutical Technology

More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.

Strategies for Preferred-Provider Partnerships

February 1, 2012

Pharmaceutical Technology

The author examines recent examples of preferred-provider collaborations.

Outsourcing to Emerging Markets: The Effect of the European Economic Crisis

February 1, 2012

Pharmaceutical Technology

Each developing economy has unique economic, political, and cultural issues that help define its pharmaceutical market. To succeed, multinational pharmaceutical companies will have to adapt differently.

Managing the Quality Relationship for a Contractual Agreement

February 1, 2012

Pharmaceutical Technology

The author describes an equation that can be used to define the Quality relationship between a contract manufacturing organization and a client, including how to factor in both party's needs and regulatory commitments.

Evaluating Competitive Forces in Contract Manufacturing

February 1, 2012

Pharmaceutical Technology

The author examines the opportunities and positioning of contract service providers.

Case Studies in Pharmaceutical Project Management

February 1, 2012

Pharmaceutical Technology

A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories.

Contract Services in 2012

February 1, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Some recent private-equity buyouts of CROs show both the upside and downside for investors.

Q&A with Gilles Cottier, SAFC

January 2, 2012
Pharmaceutical Technology

A Q&A with Gilles Cottier, president of SAFC, on recent industry trends.

Global Healthcare on the Ground: Brazil's Development Bank Leader Discusses the Country's Pharma Future

January 2, 2012

Pharmaceutical Technology

As part of the BRIC bloc with Russia, India, and China, Brazil is one of the world's leading emerging economies and is also considered by IMS Health to be one of seven pharmerging nations, which also include Mexico, Turkey, and South Korea.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here